The COVID and Translational Science supercomputer (CATS) was awarded in 2021 to enable new kinds of scientific discovery and translation related to the newly emerged COVID-19 pandemic. CATS will be in production in 4Q21 with 2,640 Intel cores, 82 TB of memory and 17 petabytes of storage. The enhanced capabilities of CATS will shorten the time to solution and enable more complex biomedical analyses. This CATS Supercomputer will be installed later in 2021. Stay tuned for more details!